Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adatomed is a specialized medical device company focused on the development and manufacture of products for ophthalmic surgery, particularly vitreoretinal procedures. The company is most recognized for its Adato Sil-ol line of high-purity silicone oils, which serve as long-term internal tamponades for treating complex retinal detachments. Additionally, Adatomed produced a range of intraocular lenses (IOLs) and microsurgical instruments. Following its acquisition by Bausch + Lomb in 1997, Adatomed's technologies and products became a core part of Bausch + Lomb's surgical retina portfolio. The brand name Adato continues to be associated with Bausch + Lomb's vitreoretinal product offerings globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adatomed.